captopril (Capoten) reduces the risk of MI, stroke, and death in patients with hypertension

New evidence now suggests that captopril (Capoten) reduces the risk of MI, stroke, and death inpatients with hypertension.

This is important.

Up until now, only beta-blockers and diuretics have been shown to reduce cardiovascular morbidityand mortality.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote